Human T cell lymphotropic virus type 1 (HTLV-1) proviral load of HTLV-associated myelopathy/tropical spastic paraparesis (HAM/TSP) patients according to new diagnostic criteria of HAM/TSP

Journal of Medical Virology

Volumn 83, Issue 7, 2011, Pages 1269-1274

  Grassi, Maria Fernanda Rios ^a,b   Olavarria, Viviana Nilla ^a,b   Kruschewsky, Ramon de Almeida ^b   Mascarenhas, Rita Elizabeth ^a,b   Dourado, Inês ^c   Correia, Luis C L ^b   de Castro Costa, Carlos Maurício ^d   Galvão Castro, Bernardo ^a,b  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b ESCOLA BAHIANA DE MEDICINA E SAÚDE PÚBLICA   (Brazil)

^c FEDERAL UNIVERSITY OF BAHIA   (Brazil)

^d FEDERAL UNIVERSITY OF CEARÁ   (Brazil)

Author keywords

Biomarker; Brazil; HAM TSP; HTLV 1; Proviral load

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; ASYMPTOMATIC INFECTION; BRAZIL; CHILD; CONTROLLED STUDY; FEMALE; HTLV 1 ASSOCIATED MYELOPATHY; HUMAN; HUMAN T CELL LEUKEMIA VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PREDICTIVE VALUE; PRESCHOOL CHILD; REAL TIME POLYMERASE CHAIN REACTION; RECEIVER OPERATING CHARACTERISTIC; SCHOOL CHILD; SENSITIVITY AND SPECIFICITY; TROPICAL SPASTIC PARAPARESIS; VIRUS LOAD;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ASYMPTOMATIC DISEASES; BIOLOGICAL MARKERS; BRAZIL; CHILD; DISEASE PROGRESSION; DNA, VIRAL; FEMALE; HTLV-I INFECTIONS; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMANS; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; PARAPARESIS, TROPICAL SPASTIC; POLYMERASE CHAIN REACTION; PREDICTIVE VALUE OF TESTS; PROVIRUSES; SPINAL CORD DISEASES; VIRAL LOAD;

HUMAN T-LYMPHOTROPIC VIRUS 1;

EID: 79955885958     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.22087     Document Type: Article

References (35)

1. Asquith B, Bangham CR. 2007. Quantifying HTLV-I dynamics. Immunol Cell Biol 85:280-286.
2. Blas M, Bravo F, Castillo W, Castillo WJ, Ballona R, Navarro P, Catacora J, Cairampoma R, Gotuzzo E. 2005. Norwegian scabies in Peru: The impact of human T cell lymphotropic virus type I infection. Am J Trop Med Hyg 72:855-857.
3. Brites C, Weyll M, Pedroso C, Badaro R. 2002. Severe and Norwegian scabies are strongly associated with retroviral (HIV-1/HTLV-1) infection in Bahia, Brazil. AIDS 16:1292-1293.
4. De Castro-Costa CM, Araujo AQ, Barreto MM, Takayanagui OM, Sohler MP, da Silva EL, de Paula SM, Ishak R, Ribas JG, Rovirosa LC, Carton H, Gotuzzo E, Hall WW, Montano S, Murphy EL, Oger J, Remondegui C, Taylor GP. 2006. Proposal for diagnostic criteria of tropical spastic paraparesis/HTLV-I-associated myelopathy (TSP/HAM). AIDS Res Hum Retroviruses 22:931-935.
5. de The G, Bomford R. 1993. An HTLV-I vaccine: Why, how, for whom? AIDS Res Hum Retroviruses 9:381-386.
6. Dehee A, Cesaire R, Desire N, Lezin A, Bourdonne O, Bera O, Plumelle Y, Smadja D, Nicolas JC. 2002. Quantitation of HTLV-I proviral load by a TaqMan real-time PCR assay. J Virol Methods 102:37-51.
7. Dourado I, Alcantara LC, Barreto ML, da Gloria Teixeira M, Galvao-Castro B. 2003. HTLV-I in the general population of Salvador, Brazil: A city with African ethnic and sociodemographic characteristics. J Acquir Immune Defic Syndr 34:527-531.
8. Gessain A, Barin F, Vernant JC, Gout O, Maurs L, Calender A, de The G. 1985. Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis. Lancet 2:407-410.
9. Goncalves DU, Proietti FA, Barbosa-Stancioli EF, Martins ML, Ribas JG, Martins-Filho OA, Teixeira-Carvalho A, Peruhype-Magalhaes V, Carneiro-Proietti AB. 2008. HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) inflammatory network. Inflamm Allergy Drug Targets 7:98-107.
10. Gotuzzo E, Moody J, Verdonck K, Cabada MM, Gonzalez E, Van Dooren S, Vandamme AM, Terashima A, Vermund SH. 2007. Frequent HTLV-1 infection in the offspring of Peruvian women with HTLV-1-associated myelopathy/tropical spastic paraparesis or strongyloidiasis. Rev Panam Salud Publica 22:223-230.
11. Hinuma Y, Nagata K, Hanaoka M, Nakai M, Matsumoto T, Kinoshita KI, Shirakawa S, Miyoshi I. 1981. Adult T-cell leukemia: Antigen in an ATL cell line and detection of antibodies to the antigen in human sera. Proc Natl Acad Sci 78:6476-6480.
12. Hlela C, Shepperd S, Khumalo NP, Taylor GP. 2009. The prevalence of human T-cell lymphotropic virus type 1 in the general population is unknown. AIDS Rev 11:205-214.
13. Ijichi S, Matsuda T, Maruyama I, Izumihara T, Kojima K, Niimura T, Maruyama Y, Sonoda S, Yoshida A, Osame M. 1990. Arthritis in a human T lymphotropic virus type I (HTLV-I) carrier. Ann Rheum Dis 49:718-721.
14. Izumo S, Goto I, Itoyama Y, Okajima T, Watanabe S, Kuroda Y, Araki S, Mori M, Nagataki S, Matsukura S, Akamine T, Nakagawa M, Yamamoto I, Osame M. 1996. Interferon-alpha is effective in HTLV-1 associated myelopathy: A multicenter, randomized, double-blind, controlled trial. Neurology 46:1016-1021.
15. Jeffery KJ, Siddiqui AA, Bunce M, Lloyd AL, Vine AM, Witkover AD, Izumo S, Usuku K, Welsh KI, Osame M, Bangham CR. 2000. The influence of HLA class I alleles and heterozygosity on the outcome of human T cell lymphotropic virus type I infection. J Immunol 165:7278-7284.
16. Jeffery KJ, Usuku K, Hall SE, Matsumoto W, Taylor GP, Procter J, Bunce M, Ogg GS, Welsh KI, Weber JN, Lloyd AL, Nowak MA, Nagai M, Kodama D, Izumo S, Osame M, Bangham CR. 1999. HLA alleles determine human T-lymphotropic virus-I (HTLV-I) proviral load and the risk of HTLV-I-associated myelopathy. Proc Natl Acad Sci USA 96:3848-3853.
17. Kwaan N, Lee TH, Chafets DM, Nass C, Newman B, Smith J, Garratty G, Murphy EL. HTLV Outcomes Study (HOST) Investigators. 2006. Long-term variations in human T lymphotropic virus (HTLV)-I and HTLV-II proviral loads and association with clinical data. J Infect Dis 194:1557-1564.
18. Kurtzke JF. 1955. A new scale for evaluating disability in multiple sclerosis. Neurology 5:580-583.
19. LaGrenade L, Hanchard B, Fletcher V, Cranston B, Blattner W. 1990. Infective dermatitis of Jamaican children: A marker for HTLV-I infection. Lancet 336:1345-1347.
20. Marinho J, Galvao-Castro B, Rodrigues LC, Barreto ML. 2005. Increased risk of tuberculosis with human T-lymphotropic virus-1 infection: A case-control study. J Acquir Immune Defic Syndr 40:625-628.
21. Mochizuki M, Yamaguchi K, Takatsuki K, Watanabe T, Mori S, Tajima K. 1992. HTLV-I and uveitis. Lancet 339:1110.
22. Morgan OS, Rodgers-Johnson P, Mora C, Char G. 1989. HTLV-1 and polymyositis in Jamaica. Lancet 2:1184-1187.
23. Nagai M, Usuku K, Matsumoto W, Kodama D, Takenouchi N, Moritoyo T, Hashiguchi S, Ichinose M, Bangham CR, Izumo S, Osame M. 1998. Analysis of HTLV-I proviral load in 202 HAM/TSP patients and 243 asymptomatic HTLV-I carriers: High proviral load strongly predisposes to HAM/TSP. J Neurovirol 4:586-593.
24. Nakada K, Kohakura M, Komoda H, Hinuma Y. 1984. High incidence of HTLV antibody in carriers of Strongyloides stercoralis. Lancet 1:633.
25. Okayama A, Stuver S, Matsuoka M, Ishizaki J, Tanaka G, Kubuki Y, Mueller N, Hsieh CC, Tachibana N, Tsubouchi H. 2004. Role of HTLV-1 proviral DNA load and clonality in the development of adult T-cell leukemia/lymphoma in asymptomatic carriers. Int J Cancer 110:621-625.
26. Olindo S, Lezin A, Cabre P, Merle H, Saint-Vil M, Edimonana Kaptue M, Signate A, Cesaire R, Smadja D. 2005. HTLV-1 proviral load in peripheral blood mononuclear cells quantified in 100 HAM/TSP patients: A marker of disease progression. J Neurol Sci 237:53-59.
27. Osame M, Usuku K, Izumo S, Ijichi N, Amitani H, Igata A, Matsumoto M, Tara M. 1986. HTLV-I associated myelopathy, a new clinical entity. Lancet 1:1031-1032.
28. Primo J, Siqueira I, Nascimento MC, Oliveira MF, Farre L, Carvalho EM, Bittencourt AL. 2009. High HTLV-1 proviral load, a marker for HTLV-1 associated myelopathy/tropical spastic paraparesis, is also detected in patients with infective dermatitis associated with HTLV-1. Braz J Med Biol Res 42:761-764.
29. Proietti FA, Carneiro-Proietti ABF, Catalan-Soares BC. 2005. Global epidemiology of HTLV-1 infection and associated diseases. Oncogene 24:6058-6068.
30. Richardson JH, Edwards AJ, Cruickshank JK, Rudge P, Dalgleish AG. 1990. In vivo cellular tropism of human T-cell leukemia virus type 1. J Virol 64:5682-5687.
31. Setoguchi Y, Takahashi S, Nukiwa T, Kira S. 1991. Detection of human T-cell lymphotropic virus type I-related antibodies in patients with lymphocytic interstitial pneumonia. Am Rev Respir Dis 144:1361-1365.
32. Silva MT, Harab RC, Leite AC, Schor D, Araujo A, Andrada-Serpa MJ. 2007. Human T lymphotropic virus type 1 (HTLV-1) proviral load in asymptomatic carriers, HTLV-1-associated myelopathy/tropical spastic paraparesis, and other neurological abnormalities associated with HTLV-1 infection. Clin Infect Dis 44:689-692.
33. Verdonck K, Gonzalez E, Henostroza G, Nabeta P, Llanos F, Cornejo H, Vanham G, Seas C, Gotuzzo E. 2007. HTLV-1 infection is frequent among out-patients with pulmonary tuberculosis in northern Lima, Peru. Int J Tuberc Lung Dis 11:1066-1072.
34. World Health Organization Scientific Group. 1989. Report on HTLV-1 Infection and Associated Diseases. Kagoshima.
35. Yakova M, Lezin A, Dantin F, Lagathu G, Olindo S, Jean-Baptiste G, Arfi S, Cesaire R. 2005. Increased proviral load in HTLV-1-infected patients with rheumatoid arthritis or connective tissue disease. Retrovirology 2:4.